Literature DB >> 11788556

Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7.

R J Fitzhenry1, D J Pickard, E L Hartland, S Reece, G Dougan, A D Phillips, G Frankel.   

Abstract

BACKGROUND: Enterohaemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli epithelial cell adhesion is characterised by intimate attachment, and attaching and effacing (A/E) lesion formation. This event is mediated in part by intimin binding to another bacterial protein, Tir (translocated intimin receptor), which is exported by the bacteria and integrated into the host cell plasma membrane. Importantly, EPEC (O127:H6) and EHEC (O157:H7) express antigenically distinct intimin types known as intimin alpha and gamma, respectively. EHEC (O157:H7) colonises human intestinal explants although adhesion is restricted to the follicle associated epithelium of Peyer's patches. This phenotype is also observed with EPEC O127:H6 engineered to express EHEC intimin gamma. AIMS: To investigate the influence of intimin on colonisation of human intestine by E coli O157:H7, and intimin types on tissue tropism in humans.
METHODS: Human intestinal in vitro organ culture with wild type and mutant strains of O157:H7 were employed.
RESULTS: Introducing a deletion mutation in the eae gene encoding intimin gamma in EHEC (O157:H7) caused the strain (ICC170) to fail to colonise human intestinal explants. However, colonisation of Peyer's patches and A/E lesion formation were restored with intimin gamma expression from a plasmid (ICC170 (pICC55)). In contrast, complementing the mutation with intimin alpha resulted in a strain (ICC170 (pCVD438)) capable of colonising and producing A/E lesions on both Peyer's patch and other small intestinal explants.
CONCLUSION: Intimin is necessary for human intestinal mucosal colonisation by E coli O157:H7. Intimin type influences the site of colonisation in a Tir type independent mechanism; intimin gamma appears to restrict colonisation to human follicle associated epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788556      PMCID: PMC1773112          DOI: 10.1136/gut.50.2.180

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  47 in total

1.  A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells.

Authors:  S Knutton; I Rosenshine; M J Pallen; I Nisan; B C Neves; C Bain; C Wolff; G Dougan; G Frankel
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

2.  Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus.

Authors:  C Jenkins; H Chart; H R Smith; E L Hartland; M Batchelor; R M Delahay; G Dougan; G Frankel
Journal:  J Med Microbiol       Date:  2000-01       Impact factor: 2.472

3.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

4.  The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; I K Wachsmuth; C Chapman; R Birden; J Brittingham; C Jackson; J Hogg
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

5.  Expression of intimin gamma from enterohemorrhagic Escherichia coli in Citrobacter rodentium.

Authors:  E L Hartland; V Huter; L M Higgins; N S Goncalves; G Dougan; A D Phillips; T T MacDonald; G Frankel
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine.

Authors:  A D Phillips; S Navabpour; S Hicks; G Dougan; T Wallis; G Frankel
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

7.  Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures.

Authors:  A D Phillips; G Frankel
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

8.  Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit.

Authors:  L R Inman; J R Cantey
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 9.  Intimin and the host cell--is it bound to end in Tir(s)?

Authors:  G Frankel; A D Phillips; L R Trabulsi; S Knutton; G Dougan; S Matthews
Journal:  Trends Microbiol       Date:  2001-05       Impact factor: 17.079

10.  Development of a universal intimin antiserum and PCR primers.

Authors:  M Batchelor; S Knutton; A Caprioli; V Huter; M Zanial; G Dougan; G Frankel
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

View more
  47 in total

1.  Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.

Authors:  Lucie Etienne-Mesmin; Valérie Livrelli; Maud Privat; Sylvain Denis; Jean-Michel Cardot; Monique Alric; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

2.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 4.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system.

Authors:  Kristen J Kanack; J Adam Crawford; Ichiro Tatsuno; Mohamed A Karmali; James B Kaper
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Colonization, persistence, and tissue tropism of Escherichia coli O26 in conventionally reared weaned lambs.

Authors:  Ilknur Aktan; Roberto M La Ragione; Martin J Woodward
Journal:  Appl Environ Microbiol       Date:  2006-12-08       Impact factor: 4.792

7.  Phylogenetic backgrounds and virulence profiles of atypical enteropathogenic Escherichia coli strains from a case-control study using multilocus sequence typing and DNA microarray analysis.

Authors:  Jan Egil Afset; Endre Anderssen; Guillaume Bruant; Josée Harel; Lothar Wieler; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

8.  Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo.

Authors:  Dianna M Jordan; Nancy Cornick; Alfredo G Torres; Evelyn A Dean-Nystrom; James B Kaper; Harley W Moon
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  The neuroendocrine stress hormone norepinephrine augments Escherichia coli O157:H7-induced enteritis and adherence in a bovine ligated ileal loop model of infection.

Authors:  Isabella Vlisidou; Mark Lyte; Pauline M van Diemen; Pippa Hawes; Paul Monaghan; Timothy S Wallis; Mark P Stevens
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Functional studies of intimin in vivo and ex vivo: implications for host specificity and tissue tropism.

Authors:  Rosanna Mundy; Stephanie Schüller; Francis Girard; John M Fairbrother; Alan D Phillips; Gad Frankel
Journal:  Microbiology (Reading)       Date:  2007-04       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.